| Jean-philippe Edouard Darche, MD | |
|
3901 Rainbow Blvd, Kansas City, KS 66160-8500 | |
| (913) 588-1902 | |
| Not Available |
| Full Name | Jean-philippe Edouard Darche |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 3901 Rainbow Blvd, Kansas City, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164836920 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 94-08388 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Kansas City Orthopaedic Institute | Leawood, KS | Hospital |
| St Lukes Hospital Of Kansas City | Kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
| Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
News Archive
Masimo announced today the findings of an abstract presented at the 2018 Congress of the French Society of Anesthesia and Resuscitation in Paris in which researchers at CHU Angers in France investigated the ability of Masimo ORi™ to help clinicians reduce the number of days ICU patients experience hyperoxemia while on mechanical ventilation.
Teva Pharmaceutical Industries Ltd., announced today that the European Commission has granted marketing authorization for DuoResp Spiromax for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD) where the use of a combination of an inhaled corticosteroid and long-acting beta2-adrenoceptor agonist is appropriate.
Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.
Previous studies have established that black patients have a higher risk for knee replacement revision. Black patients also report significantly more pain and worse joint function two years after surgery compared to white patients.
› Verified 4 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
Masimo announced today the findings of an abstract presented at the 2018 Congress of the French Society of Anesthesia and Resuscitation in Paris in which researchers at CHU Angers in France investigated the ability of Masimo ORi™ to help clinicians reduce the number of days ICU patients experience hyperoxemia while on mechanical ventilation.
Teva Pharmaceutical Industries Ltd., announced today that the European Commission has granted marketing authorization for DuoResp Spiromax for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD) where the use of a combination of an inhaled corticosteroid and long-acting beta2-adrenoceptor agonist is appropriate.
Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.
Previous studies have established that black patients have a higher risk for knee replacement revision. Black patients also report significantly more pain and worse joint function two years after surgery compared to white patients.
› Verified 4 days ago
| Entity Name | Jayhawk Primary Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528025053 PECOS PAC ID: 8123928900 Enrollment ID: O20050721001078 |
News Archive
Masimo announced today the findings of an abstract presented at the 2018 Congress of the French Society of Anesthesia and Resuscitation in Paris in which researchers at CHU Angers in France investigated the ability of Masimo ORi™ to help clinicians reduce the number of days ICU patients experience hyperoxemia while on mechanical ventilation.
Teva Pharmaceutical Industries Ltd., announced today that the European Commission has granted marketing authorization for DuoResp Spiromax for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD) where the use of a combination of an inhaled corticosteroid and long-acting beta2-adrenoceptor agonist is appropriate.
Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.
Previous studies have established that black patients have a higher risk for knee replacement revision. Black patients also report significantly more pain and worse joint function two years after surgery compared to white patients.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jean-philippe Edouard Darche, MD 3901 Rainbow Blvd, Kansas City, KS 66160-8500 Ph: () - | Jean-philippe Edouard Darche, MD 3901 Rainbow Blvd, Kansas City, KS 66160-8500 Ph: (913) 588-1902 |
News Archive
Masimo announced today the findings of an abstract presented at the 2018 Congress of the French Society of Anesthesia and Resuscitation in Paris in which researchers at CHU Angers in France investigated the ability of Masimo ORi™ to help clinicians reduce the number of days ICU patients experience hyperoxemia while on mechanical ventilation.
Teva Pharmaceutical Industries Ltd., announced today that the European Commission has granted marketing authorization for DuoResp Spiromax for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD) where the use of a combination of an inhaled corticosteroid and long-acting beta2-adrenoceptor agonist is appropriate.
Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.
Previous studies have established that black patients have a higher risk for knee replacement revision. Black patients also report significantly more pain and worse joint function two years after surgery compared to white patients.
› Verified 4 days ago
Faith Madeline Butler, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd # Ms 4010, Kansas City, KS 66160 Phone: 913-588-1908 | |
William S Greiner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2040 Hutton Rd, Suite 102, Kansas City, KS 66109 Phone: 913-299-3700 Fax: 913-299-3050 | |
Dr. Jane E Stewart, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8929 Parallel Pkwy, Kansas City, KS 66112 Phone: 913-660-1616 Fax: 913-660-1664 | |
Margaret A Killam, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8101 Parallel Pkwy, Ste 100, Kansas City, KS 66112 Phone: 913-299-9200 Fax: 913-299-9210 | |
Michael M Parra, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8101 Parallel Pkwy Ste 100, Kansas City, KS 66112 Phone: 913-299-9200 Fax: 913-299-9210 | |
Eric Aspinwall, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1610 Washington Blvd, Kansas City, KS 66102 Phone: 913-281-2605 Fax: 913-281-0087 | |
Dr. Lee Alan Norman, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3901 Rainbow Blvd, University Of Ks Hospital Heo, Kansas City, KS 66103 Phone: 913-588-1108 Fax: 913-588-1280 |